Genprex Inc News - GNPX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of...

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024...

Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting

Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for...

Form 8-K - Current report

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes PR...

Genprex Announces Formation of Mesothelioma Clinical Advisory Board

Genprex Announces Formation of Mesothelioma Clinical Advisory Board PR Newswire AUSTIN, Texas, Sept. 19, 2024...

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024...

Form 8-K - Current report

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1...

laraz5 2 weeks ago

Unlimited theft in the name of Cancer research?

It's one thing to create an imaginary product and sell shares of its ideas?

But to sell shares based on the idea of combating cancer takes some sick people?

IMO

👍️0

georgie18 2 weeks ago

GNPX...$1.26...🥳...AUSTIN, Texas , Dec. 16, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has completed the Phase 1 dose escalation portion of the Acclaim-3 clinical trial of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with Tecentriq® (atezolizumab) as maintenance therapy to treat patients with extensive stage small cell lung cancer (ES-SCLC). In addition, the Safety Review Committee (SRC) has approved the opening of the Phase 2 expansion portion of the trial.

The combination of REQORSA and atezolizumab previously received U.S. Food and Drug Administration's (FDA) Fast Track Designation for the treatment of the Acclaim-3 patient population, and the FDA has also granted Orphan Drug Designation to REQORSA for the treatment of SCLC.

Based on full safety data, which showed no dose limiting toxicities (DLTs), the SRC determined that the Recommended Phase 2 Dose (RP2D) of REQORSA will be 0.12 mg/kg. This was the highest dose level delivered in the Phase 1 portion of the trial. The SRC also recommended the trial advance to the Phase 2 expansion portion of the study, which the Company has now opened for enrollment.

👍️0

BurgerKing82 2 weeks ago

Looking good...P.T?

👍️0

georgie18 2 weeks ago

GNPX...$1.12...🥳...Psar flipped Bullish...Bollies are starting to Squeeze here...Been averaging down and Accumulating...

👍️0

laraz5 1 month ago

New O/S 8,508,068 six million shares diluted since last report month back?

6 million shares while the con artist 3rd party promoters came in and played pump n dump with the shell?

Don't anyone worry the O/S is going much higher and the PPS is going much lower?

Does Ryan M Confer understand about pyramid schemes?

I believe Rodney Varner is going to have some explaining to do where he is headed?

If Ryan M Confer turned out to take the torch from Varner by getting cancer products tweaking them and diluting shares while creating a false hope then this won't be his last time getting involved in possible pyramid schemes?

IMO

👍️0

laraz5 1 month ago

You think you know the current O/S or will you guess at that as well?

GNPX is a pyramid scheme?

IMO

👍️0

Savannah-Marc 1 month ago

I think it will run but "when" is the question, depends on if we get a favorable settlement or judgement from the court case. I think the appellant is running the clock to come up with a decent enough settlement agreement because in my opinion, a court decision would ruin them.

What's the current O/S? Since shamelessly promoting a pyramid scheme tanking daily off news at least tell shareholders what's the current O/S is?

Unless you simply don't know it?

Stop promoting scams?

IMO

👍️0

georgie18 1 month ago

GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html

👍️0

laraz5 2 months ago

Scoop like cat litter? Does Ryan know where this possible pyramid scheme was originated and how this ends for him?

Does Ryan Confer just get to walk away after a possible billions are diluted and GNPX tumbles into BK?

Michael T Redmands stank is still riddled in this mess?

IMO

👍️0

CelestialEnchanter69 2 months ago

Get the Inside Scoop on Genprex
Want to know more about Genprex (NASDAQ: GNPX)? Watch the exclusive interview with CEO Ryan Confer. He discusses the company's latest developments in diabetes and oncology.
Join the Future 1% community for free to access this insightful interview and other exclusive content.

https://marathonmoneyplus.com/2024/10/28/marathon-money-ft-ceo-mr-ryan-m-confer-m-s-genprex-gnpx/

#MarathonMoney #Future1% #GNXP #biotech #investing

👍️0

laraz5 2 months ago

GNPX is failing to disclose the O/S?

Is it still 2.5 million?

Or 50,000?

They seem to have neglected any reporting since August?

Seems like a Michael Redmond type of pyramid scheme?

Oh don't worry they fired him after he drew them a blueprint?

Bankruptcy soon but no jail time they all get away with it?

IMO

👍️0

laraz5 2 months ago

2.09? Hahaha loser 3rd party promoters trying to sell crap? It reduced tumors?

Does anyone believe such garbage?

These animals come around screaming about falsehoods while they sell?

GNPX could very well be a pyramid scheme selling millions and millions of shares while low intelligence 3rd party cons come in and drop lies?

Already down another 10%?

Keep them newsletters coming con artists?

Don't believe me then tell me what the O/S is today?

IMO

👍️0

tw0122 2 months ago

Reduced tumors in mice, regained compliance,
Low floater $2.09.
GNS nice flip last night

👍️0

Invest-in-America 2 months ago

GNPX: Too bad TRUMP got in --- if he hadn't, all that Bitcoin crap would NEVER have gone anywhere and, as such, we would have a lot more SUBSTANTIVE stocks to think about.

Bitcoin Definition: "A solution to a problem that NEVER existed in the first place."

👍️0

tw0122 2 months ago

Heads-up last night but so many up today)2.07 + 50%

👍️0

TrendTrade2016 2 months ago

GNPX ON THE MOVE

👍️0

georgie18 2 months ago

GNPX...$1.82...Bouncing off the 100ma...🥳

georgie18

Member Level
Re: georgie18 post# 4009

Thursday, November 07, 2024 9:55:03 AM

Post#
4010
of 4016
GNPX...$1.77...🥳

georgie18

Member Level
Re: georgie18 post# 663002

Thursday, November 07, 2024 8:44:53 AM

Post#
663957
of 663985
GNPX...$1.60... https://schrts.co/nfchkggS ...🥳...Bullish 3 Gap Downs Reversal Pattern...Lets see if the pattern sticks...

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...

👍️0

glenn1919 2 months ago

GNPX..........................https://stockcharts.com/h-sc/ui?s=GNPX&p=W&b=5&g=0&id=p86431144783

👍️0

laraz5 2 months ago

Now down 1.50 since this epic horror call?

Where do they find them?

Shameful?

Shame?

Shame?

IMO

👍️0

laraz5 2 months ago

Complete and Total horseshit?

Your continues pre pump and post pump R/S is nonsense?

Shame on you?

IMO

👍️0

georgie18 2 months ago

Are you a moron or do you just play one on Ihub...I alerted GNPX at .37 and it ran to $4 range...you failed to mention that...oops...I don't pump and I do not have and subscribers...🥳

Don't post shit you have no idea about...Have Great Day...

👍️0

laraz5 2 months ago

Now down 50% since you pumped 2.70?

What type of promotion is GNPX?

This is the worst collapse since the hindenburg disaster?

Can any of your subscribers get a refund is they purchased?

IMO

👍️0

georgie18 2 months ago

Have a Great Weekend Y'all...🥳

👍️0

georgie18 2 months ago

GNPX...$1.77...🥳

georgie18

Member Level
Re: georgie18 post# 663002

Thursday, November 07, 2024 8:44:53 AM

Post#
663957
of 663985
GNPX...$1.60... https://schrts.co/nfchkggS ...🥳...Bullish 3 Gap Downs Reversal Pattern...Lets see if the pattern sticks...

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...

👍️0

georgie18 2 months ago

GNPX...$1.60... https://schrts.co/nfchkggS ...🥳...Bullish 3 Gap Downs Reversal Pattern...Lets see if the pattern sticks...

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...

👍️0

laraz5 2 months ago

Hey GNPX is the O/S still 2.5 million? It's been months since you updated?

Are you stealing or not?

Prove me wrong about a pyramid scam being produced off a previous failure?

IMO

👍️0

laraz5 2 months ago

They inflated the PPS to sell more shares?

Toxic finance pyramid scheme based of hypethical nonsense?

IMO

👍️0

laraz5 2 months ago

Diluted pyramid scam O/S continues its rise and the news keeps pouring out?

Pump and dump?

Mike Redmond originated con job?

IMO

👍️0

SolarRevolution 2 months ago

Tumour remission documented by three university's and patents applied for!!!

👍️0

SolarRevolution 2 months ago

Good support after hours lung cancer tumours remission data and two patents applied for!

👍️0

georgie18 2 months ago

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...

👍 1

SolarRevolution 2 months ago

Great day glad I held!

👍️0

glenn1919 2 months ago

GNPX......................https://stockcharts.com/h-sc/ui?s=GNPX&p=W&b=5&g=0&id=p86431144783

👍 1

georgie18 2 months ago

GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...

👍 1

georgie18 2 months ago

GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...

👍️0

SolarRevolution 2 months ago

Ready to get back to the action, lung cancer tumour remission data will not take long to get out to major partners, fast track fda approval should be the catalyst for quick buyout and bidding war over shares of Genprex.

Lung cancer tumours in remission !! Very good news all through October 2024, November will be good for shareholders!

👍️0

georgie18 2 months ago

Have a Great Weekend Y'all...🥳

👍 1

SolarRevolution 2 months ago

Looks life some life back in this, word is very impressive updates after the conference concludes today in Spain , lung cancer treatment with impressive results 30% remission of tumours !

👍️0

The_BORG 2 months ago

Where are your great 14$ ???

lol !!!

Down 20% every day, falling like a stone towards 0
But what else can you read here.... Only dreamers and hopefuls who don't understand that they are constantly being bloodily screwed by big short addresses....

👍️0

SolarRevolution 2 months ago

Word is more results to be announced after the October 23-25 conference happening now in Spain 🇪🇸

👍️0

The_BORG 2 months ago

blah blah blah

just one bloody gambler and soldier of fortune....
If it goes well, they brag again, if it goes down the drain you don't hear a word more....
as always.....

👍️0

georgie18 2 months ago

GNPX...$2.27...🥳Following the gap fill...

georgie18

Member Level
Re: georgie18 post# 3986

Thursday, October 24, 2024 10:09:46 AM

Post#
3989
of 3990
GNPX...$2.17...Open Gap filled...🥳

georgie18

Member Level
Re: georgie18 post# 662307

Wednesday, October 23, 2024 10:05:02 AM

Post#
662384
of 662554
GNPX...$2.90...Holding and bidding the $2.20 range open gap...🥳

👍️0

The_BORG 2 months ago

Sorry, just a lot of blah blah blah and the great stock continues to fall like a stone towards 0
That's a fact....

You have only lured tens of thousands of investors into the stock with your dreams, who are now already sitting on a good 50% loss...

and you go on and on with your sick self-promotion...

sick !

👍️ 1

georgie18 2 months ago

GNPX...$2.17...Open Gap filled...🥳

georgie18

Member Level
Re: georgie18 post# 662307

Wednesday, October 23, 2024 10:05:02 AM

Post#
662384
of 662554
GNPX...$2.90...Holding and bidding the $2.20 range open gap...🥳

👍️0

SolarRevolution 2 months ago

Share structure is tight, I like it. Huge upside potential if the results are really this good! Worth taking a few days to hold at this point, and great entry point. I'm in at $3.80 and if the science is firm and confirmed, investors will be piling up their bids BIG TIME!

The company has alluded to 30% tumour reduction in form of lung cancer, and only a three month trials. Suggesting the efficacy of Genprex's product due to all patients seeing improvement through the trail criteria's over the partner drug. So I'm betting that this is a very important lung cancer treatment breakthrough! Will be fast tracked so fast heads will spin!

👍️0

SolarRevolution 2 months ago

Hope the conference in Spain generates some hype

👍️0

georgie18 2 months ago

GNPX...$2.90...Holding and bidding the $2.20 range open gap...🥳

👍️0

Invest-in-America 2 months ago

GNXP: Coming UP out from the red ink somewhat right now.

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Genprex Inc (GNPX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

GNPX News

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting

Form 8-K - Current report

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes

Genprex Announces Formation of Mesothelioma Clinical Advisory Board

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Form 8-K - Current report

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

GNPX Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Genprex Inc (GNPX) News

Genprex Inc (GNPX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

GNPX News

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting

Form 8-K - Current report

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes

Genprex Announces Formation of Mesothelioma Clinical Advisory Board

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Form 8-K - Current report

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

GNPX Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free